MARKET

VCYT

VCYT

Veracyte
NASDAQ

Real-time Quotes | Nasdaq Last Sale

30.15
-0.02
-0.07%
Closed 16:11 01/17 EST
OPEN
30.48
PREV CLOSE
30.17
HIGH
30.86
LOW
29.93
VOLUME
345.04K
TURNOVER
--
52 WEEK HIGH
31.18
52 WEEK LOW
15.82
MARKET CAP
1.47B
P/E (TTM)
-156.7048
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of VCYT and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

VCYT News

  • Veracyte Announces Biopharmaceutical Collaboration With Acerta Pharma
  • Benzinga.01/08 13:22
  • Veracyte Announces Biopharmaceutical Collaboration with Acerta Pharma
  • Business Wire.01/08 13:15
  • Hedge Funds Might Be Selling Veracyte Inc (VCYT), But They Are Still Bullish
  • Insider Monkey.12/13/2019 14:06
  • V&M Premium Portfolio: 2019 End Of Year Report Card Through Week 49
  • Seeking Alpha - Article.12/10/2019 10:29

More

Industry

Biotechnology & Medical Research
-0.16%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About VCYT

Veracyte, Inc. is a genomic diagnostics company. The Company, through its scientific platform, which utilizes ribonucleic acid (RNA), whole-transcriptome sequencing combined with machine learning, produces genomic tests. It provides various genomic tests, including Afirma Genomic Sequencing Classifier (GSC), Percepta Bronchial Genomic Classifier, Envisia Genomic Classifier and Afirma Xpression Atlas. It provides GSC tests for thyroid cancer. It provides Percepta Bronchial Genomic Classifier tests for lung cancer. It provides Envisia Genomic Classifier tests for idiopathic pulmonary fibrosis (IPF). Its Afirma Xpression Atlas provides information on gene alterations associated with thyroid cancer, enabling physicians to tailor surgical and treatment decisions at time of diagnosis.
More

Webull offers Veracyte Inc (VCYT) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.